x

Cell Manufacturing

A team of trainees from the NIH Cell and Tissue Engineering Training Program (CTEng) and the NSF Engineering Research Center for Cell Manufacturing Technologies (CMaT) visited global pharma company Celgene.
Trainees Gain Cell Manufacturing Industry Insight

Grad students from Georgia Tech and three other universities get rare close-up look at big pharma facility
Krish Roy and Johnna Temenoff, director and deputy director of CMaT, respectively, prepare the room for the next session.
Setting the Standards for New Therapeutics

Georgia Tech and CMaT host ASTM International workshop focused on cell and tissue manufacturing
Krish Roy delivered the opening remarks.
Patient’s Story Stirs CMaT Audience

NSF Cell Manufacturing Technologies Center gathering in Athens for annual retreat
Close-up image shows the Dynamic Mass Spectrometry Probe developed to monitor the health of living cell cultures. (Credit: Rob Felt, Georgia Tech)  
Microfluidic Molecular Exchanger Helps Control Therapeutic Cell Manufacturing

Researchers have demonstrated an integrated technique for monitoring specific biomolecules.
Yasmine Stewart, a biology major from Savannah State University, worked in the laboratory of Lohitash Karumbaiah, assistant professor in the College of Agricultural & and Environmental Sciences at the University of Georgia. (Credit: Brice Zimmerman, Georgia Tech)
Summer Lab Experience Helps Launch Industry and Research Careers

Undergraduate students from around the United States spent their summer learning about cell manufacturing.
Krishnendu Roy
FDA Fueling Cell Manufacturing Research at Georgia Tech

Marcus Center leading three-year collaborative effort with GTRI, ISyE and Duke University
A plaque is unveiled in the new Good Manufacturing Practice (GMP) like facility that is part of the Marcus Center for Therapeutic Cell Characterization and Manufacturing (MC3M). Shown are Georgia Tech President G.P. “Bud” Peterson, Center Director Krishnendu Roy, and philanthropist Bernie Marcus. (Credit: Rob Felt, Georgia Tech)
New Cell Manufacturing Research Facility will Change Approaches to Disease Therapies

On June 6, Georgia Tech dedicated a Good Manufacturing Practice (GMP) like ISO 8 and ISO 7 facility.
This small-scale bioreactor is the model for how cell manufacturing exists on the industrial scale. (Credit: Rob Felt, Georgia Tech)
New Partnership to Advance Production Standards in Biomanufacturing

The Georgia Institute of Technology will play a key role in a new public-private partnership to help establish best practices and eventual industry-wide standards for the production of therapies using living cells to treat a range of conditions.
Researchers work in the cell manufacturing laboratory of Krishnendu Roy at Georgia Tech. Shown (l-r) are NSF Graduate Research Fellow Joscelyn Mejias, Research Experience for Undergraduates (REU) Program student Angela Jimenez, (background) Postdoctoral Fellow Randall Toy, Georgia Tech Research Institute TAG-Ed High School Intern Gita Balakirsky, and Project ENGAGES High School Intern Ayanna Prather. (Credit: Rob Felt, Georgia Tech)
Engineering Research Center Will Help Expand Use of Therapies Based on Living Cells

A $20 million engineering research center will help expand the uses of cell-based therapies.